On March 22, CSPC Pharmaceutical Group officially announced that its SARS-CoV-2 mRNA VACCINE (SYS6006) was included in emergency use in China, and China ushered in the first domestic mRNA COVID-19 vaccine.Since the outbreak of the COVID-19, mRNA technology has attracted much attention due to its outstanding safety and short production cycle. According to incomplete statistics, about 16 mRNA COVID-19 vaccines are under development in China. When COVID-19 recedes globally, it is not yet known how much commercial value the subsequent vaccines will gain. Still, the deployment of mRNA vaccines is an important step in entering the emerging field of mRNA therapy for many Chinese ...